Hypotony in Patients with Uveitis: The Multicenter Uveitis Steroid Treatment (MUST) Trial.

MLA

Sen, H.Nida, et al. “Hypotony in Patients with Uveitis: The Multicenter Uveitis Steroid Treatment (MUST) Trial.” Ocular Immunology & Inflammation, vol. 20, no. 2, Apr. 2012, pp. 104–12. EBSCOhost, https://doi.org/10.3109/09273948.2011.647228.

APA

Sen, H. N., Drye, L. T., Goldstein, D. A., Larson, T. A., Merrill, P. T., Pavan, P. R., Sheppard, J. D., Burke, A., Srivastava, S. K., & Jabs, D. A. (2012). Hypotony in Patients with Uveitis: The Multicenter Uveitis Steroid Treatment (MUST) Trial. Ocular Immunology & Inflammation, 20(2), 104–112. https://doi.org/10.3109/09273948.2011.647228

Chicago

Sen, H. Nida, Lea T. Drye, Debra A. Goldstein, Theresa A. Larson, Pauline T. Merrill, Peter R. Pavan, John D. Sheppard, Alyce Burke, Sunil K. Srivastava, and Douglas A. Jabs. 2012. “Hypotony in Patients with Uveitis: The Multicenter Uveitis Steroid Treatment (MUST) Trial.” Ocular Immunology & Inflammation 20 (2): 104–12. doi:10.3109/09273948.2011.647228.